Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayMay 03, 2024 9:00 am

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Moves Toward Feasibility Study, Exploration at Kenbridge Nickel Project on Strength of PEA Report

Tartisan originally released a Preliminary Economic Assessment (“PEA”) report in 2022, which confirmed the significant nickel-copper-cobalt mineral resource at its 100%-owned Kenbridge Nickel Project The PEA noted that the measured and indicated mineral resources represent 3,508,000 tons at 0.70% Ni, 0.35% Cu, and 0.01% Co (54 Mlb Ni, 27 Mlb Cu), while inferred mineral resources represent 1,013,000 tones at 1.21% Ni, 0.56% Cu, and 0.01% Co (27 Mlb Ni, 13 Mlb Cu) The PEA also indicated a 9-year mine plan based on a 1,500-ton-per-day underground mining and processing operation The company transitioned to the Advanced Exploration (“AEX”) and Project Development…

Continue Reading

ThursdayMay 02, 2024 12:00 pm

BizCann Expo Brings Cannabis Business to Latin America

BizCann invites traders, vendors, entrepreneurs, regulatory authorities, investors, and cannabis enthusiasts, to attend the BizCann Expo being held in Medellin, Colombia, May 18-19, 2024. The BizCann Expo is organized by ZJ Events, bringing the businesses and professionals of the cannabis industry and its ancillaries to a common forum for networking, trading, and learning sessions. Having spread its reach over several cities in the US, BizCann Expo is being held in Medellin, Colombia, this year to offer phenomenal trading opportunities to local businesses. Due to its favorable location, connectivity, and rich history, Medellin offers the perfect venue for hosting this networking…

Continue Reading

ThursdayMay 02, 2024 11:15 am

Vape South America is Coming to Medellín

The ZJ Events Vape South America 2024 will be held at the Plaza Mayor Convention Center, Medellin Colombia, May 18-19, 2024. Top manufacturers, buyers, suppliers, users, traders, enthusiasts, and stalwarts of the alternative products industry will be attending the always popular event. The counterculture and vape trade show will showcase a myriad of alternative products that include herbal products, mood enhancers, vape products, functional beverages, dietary supplements, nootropics, and more. Suppliers, traders, head shops, and several businesses from the alternative category, will be part of the Expo, to showcase their latest products and services. Attendees can leverage huge discounts, get…

Continue Reading

ThursdayMay 02, 2024 10:30 am

Simplifying Healthcare Appointments: How HealthLynked Corp. (HLYK) is Revolutionizing Online Booking with a Patient-Focused Approach

In an era where convenience and efficiency stand as pillars of service delivery, HealthLynked (OTCQB: HLYK) has introduced an innovative online patient booking system, akin to how OpenTable simplifies restaurant reservations. This seamless integration of technology and healthcare is transforming how patients interact with medical services, ensuring that setting up a doctor's appointment is as easy as booking a dinner date. The Booking Process: Tailored for Simplicity and Flexibility HealthLynked's online booking system is designed with the user experience at the forefront. The process is straightforward: patients select their preferred doctor, date, and whether they prefer a morning or afternoon…

Continue Reading

ThursdayMay 02, 2024 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Reports Record Revenues, EBITDA and Gross Margin Growth, in Annual Fiscal Conference Call

SuperCom Ltd. is focused on developing its portfolio of products in support of advanced electronic monitoring (“EM”) solutions, and reported last month record-level revenues and EBITDA during the past year SuperCom’s recent positive financials report represents the results of the company’s efforts to introduce non-incarceration EM alternatives around the world, with inroads in Europe and the U.S. resulting in significant contracts Electronic technology for tracking criminal offenders and other court-administered programs provides a more economical approach to security than incarceration in cases where such options applicable Electronic-monitoring (“EM”) security solutions developer SuperCom (NASDAQ: SPCB) has seen its revenues and gross…

Continue Reading

ThursdayMay 02, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Fast-Anneal Feature Availability in Leap(TM) Quantum Cloud Service

Fast anneal is expected to impact various quantum computing applications, from advanced scientific research in quantum simulation to AI and solving real-world problems across wide spectrum of industries It expands upon D-Wave's groundbreaking optimization achievements, utilizing the comprehensive coherent annealing quantum computing provided by D-Wave's Advantage(TM) systems and the cutting-edge Advantage2(TM) prototype The introduction of the fast-anneal feature is poised to attract both commercial and academic researchers aiming to develop top-tier applications, broaden benchmarking investigations, and correlate heightened coherence with enhanced performance D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world's first commercial…

Continue Reading

WednesdayMay 01, 2024 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

PaxMedica has completed its three registration/validation batches of PAX-101, an IV formulation of suramin The completed batches are a significant step toward submitting a New Drug Application to the U.S. Food and Drug Administration in the fourth quarter of 2024 PaxMedica aims to establish a sustainable global supply chain for PAX-101 and to advance research and clinical trials targeting Autism Spectrum Disorder (“ASD”), demonstrating a steadfast commitment to addressing complex neurological conditions The ASD treatment market size was valued at $6.94 billion in 2022 and is projected to grow to $13.14 billion by 2030 PaxMedica (NASDAQ: PXMD), a biopharmaceutical company…

Continue Reading

WednesdayMay 01, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting

Long-term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 exhibited significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p < 0.05) Significantly enhanced clinical outcomes were associated with long-term daily oral CNM-Au8(R) 30 mg treatment (change from original baseline; p < 0.05) Long-term administration of CNM-Au8, spanning up to three years, was well-tolerated, with no significant safety concerns identified This marks the first Phase 2 clinical trial in MS utilizing a non-immunomodulatory drug to achieve a clinical outcome demonstrating improved function supporting remyelination and reparative effects Clene (NASDAQ: CLNN), along with its…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000